Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07836010
PHASE4

Suzetrigine Added to Multimodal Analgesia for Women Undergoing Minimally Invasive Hysterectomy

Sponsor: Duke University

View on ClinicalTrials.gov

Summary

This study will assess the analgesic efficacy of suzetrigine as part of a multimodal analgesic regimen in women undergoing laparoscopic or robotic hysterectomy. Outcomes will be compared with matched historical controls receiving the current ERAS regimen without suzetrigine.

Official title: The Impact of Adding Suzetrigine to Multimodal Analgesia for Minimally Invasive Hysterectomy

Key Details

Gender

FEMALE

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

123

Start Date

2026-11

Completion Date

2028-02

Last Updated

2026-09-23

Healthy Volunteers

No

Interventions

DRUG

Suzetrigine

Suzetrigine is an oral non-opioid pain medication used to treat moderate-to-severe acute pain in adults.